Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 3
2006 6
2007 3
2008 4
2009 10
2010 6
2011 8
2012 7
2013 12
2014 11
2015 9
2016 6
2017 5
2018 2
2019 3
2020 3
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia.
Park YH, Kim DY, Mun YC, Cho EK, Lee JH, Jo DY, Kim I, Yoon SS, Park SY, Kim B, Bang SM, Kim H, Min YJ, Park JH, Seo JJ, Moon HN, Lee MH, Kim CS, Lee WS, Chong SY, Oh D, Zang DY, Lee KH, Hyun MS, Kim HS, Kim SH, Kwon H, Kim HJ, Park KT, Bae SH, Ryoo HM, Choi JH, Ahn MJ, Yoon HJ, Nam SH, Kim BS, Seong CM. Park YH, et al. Among authors: ryoo hm. Korean J Intern Med. 2022 Jul;37(4):841-850. doi: 10.3904/kjim.2021.468. Epub 2022 Jun 28. Korean J Intern Med. 2022. PMID: 35811370 Free PMC article.
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea.
Ahn SY, Son SK, Lee GH, Kim I, Cheong JW, Lee WS, Kim BS, Jo DY, Jung CW, Seong CM, Lee JH, Yuh YJ, Kim MK, Ryoo HM, Park MR, Cho SH, Kim HG, Zang DY, Park J, Kim H, Lee S, Kim SH, Chang MH, Lee HS, Choi CW, Kwon J, Lim SN, Oh SJ, Joo I, Kim DW. Ahn SY, et al. Among authors: ryoo hm. Blood Res. 2022 Jun 30;57(2):144-151. doi: 10.5045/br.2022.2021137. Epub 2022 Jun 10. Blood Res. 2022. PMID: 35678158 Free PMC article.
Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.
Yi JH, Kim SJ, Yoon DH, Suh C, Chang MH, Yang DH, Jo JC, Hyun SY, Eom HS, Lee JO, Kwon JH, Han SH, Lee SS, Kwak JY, Kim SH, Kim DS, Lee JH, Oh SY, Ryoo HM, Kim HJ, Kim WS. Yi JH, et al. Among authors: ryoo hm. Cancer Commun (Lond). 2021 Mar;41(3):275-278. doi: 10.1002/cac2.12150. Epub 2021 Feb 24. Cancer Commun (Lond). 2021. PMID: 33626235 Free PMC article. No abstract available.
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
Hong S, Lee JH, Chun EK, Kim KI, Kim JW, Kim SH, Lee YG, Hwang IG, Kim JY, Koh SJ, Ko YH, Shin SH, Woo IS, Kim TY, Baek JY, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Ryoo HM, Kim JH. Hong S, et al. Among authors: ryoo hm. Oncologist. 2020 Mar;25(3):e502-e511. doi: 10.1634/theoncologist.2019-0085. Epub 2019 Nov 27. Oncologist. 2020. PMID: 32162799 Free PMC article.
Interference with daily functioning by breakthrough pain in patients with cancer.
Kang JH, Koh SJ, Oh SY, Kim RB, Shin SH, Lee YG, Kim BS, Ryoo HM, Yoon SY, Jang JS, Oh HS, Choi YJ, Lee MH, Lee KH. Kang JH, et al. Among authors: ryoo hm. Support Care Cancer. 2020 Nov;28(11):5177-5183. doi: 10.1007/s00520-020-05329-9. Epub 2020 Feb 14. Support Care Cancer. 2020. PMID: 32056013
Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative Chemotherapy.
Kim JW, Kim SH, Lee YG, Hwang IG, Kim JY, Koh SJ, Ko YH, Shin SH, Woo IS, Hong S, Kim TY, Baek JY, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Ryoo HM, Lee KH, Kim JH. Kim JW, et al. Among authors: ryoo hm. Cancer Res Treat. 2019 Jul;51(3):1249-1256. doi: 10.4143/crt.2018.451. Epub 2019 Jan 2. Cancer Res Treat. 2019. PMID: 30653746 Free PMC article.
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer.
Kim DW, Kim HG, Kim JH, Park K, Kim HK, Jang JS, Kim BS, Kang JH, Lee KH, Kim SW, Ryoo HM, Kim JS, Lee KH, Kwon JH, Choi JH, Shin SW, Hahn S, Heo DS. Kim DW, et al. Among authors: ryoo hm. Cancer Res Treat. 2019 Jan;51(1):119-127. doi: 10.4143/crt.2018.019. Epub 2018 Mar 12. Cancer Res Treat. 2019. PMID: 29529858 Free PMC article. Clinical Trial.
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.
Lee JH, Kim H, Joo YD, Lee WS, Bae SH, Zang DY, Kwon J, Kim MK, Lee J, Lee GW, Lee JH, Choi Y, Kim DY, Hur EH, Lim SN, Lee SM, Ryoo HM, Kim HJ, Hyun MS, Lee KH; Cooperative Study Group A for Hematology. Lee JH, et al. Among authors: ryoo hm. J Clin Oncol. 2017 Aug 20;35(24):2754-2763. doi: 10.1200/JCO.2017.72.8618. Epub 2017 Jun 20. J Clin Oncol. 2017. PMID: 28632487 Clinical Trial.
85 results